Selected research funding (in alphabetical order):

Project: The role of the insulin-like growth factor (IGF) signaling pathway in the tumorigenesis and development of cerebellar progenitor cells. / LINK

Project: Relevance of regulator proteins of actin remodeling for the gain of an invasive phenotype in Ewing’s sarcoma. In cooperation with Konrad Steinestel and Uta Dirksen. / LINK

Project: Identification and characterization of molecular targets in sarcoma cell lines as a basis of innovative therapeutic strategies - Interdisciplinary research group KoSar (Sarcoma competence network). / LINK

Project: Analysis of the molecular function of the WNT signaling pathway in synovial sarcoma. / LINK

Travel grant: AACR (American Association for Cancer Research) Annual Meeting, Washington USA / LINK

(I) Project: Generation and therapeutic application of sarcoma-associated chromosomal translocations with the RNA-guided CRISPR-Cas9 system.

(II) Project: Functional characterization of different transcription factors in the context of the activated PI3K signaling pathway in myxoid liposarcoma.

/ LINK

Project: Functional characterization of transcription factors in synovial sarcoma. / LINK

(I) Project: Analysis of the functional role of effectors of cytoskeletal dynamics the genesis and progression of synovial sarcoma as the basis of molecular therapeutic approaches. In cooperation with Konrad Steinestel.

(II) Project: The significance of the WNT-, Hedgehog-, und NOTCH-signaling pathways in synovial sarcoma as potential targets in molecularly targeted therapeutic approaches.

/ LINK

 
 
 
 

CONTACT

GDI - CANCER RESEARCH LAB

T (Lab):

+49 (0)251/83-57626 or -58464

T (Office):

+49 (0)251/83-55444 or -58461

Fax: +49 (0)251-83-57559

Visiting address (Google maps):

Domagkstr. 17

48149 Münster, Germany

Our cancer research lab is located at the Gerhard-Domagk-Institute of Pathology / University Hospital Münster (UKM), Germany